These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24287774)

  • 1. Charles Hugh-Jones. Interview by Asher Mullard.
    Hugh-Jones C
    Nat Rev Drug Discov; 2013 Dec; 12(12):900. PubMed ID: 24287774
    [No Abstract]   [Full Text] [Related]  

  • 2. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 3. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

  • 4. Paul Brown. Interview by Asher Mullard.
    Brown P
    Nat Rev Drug Discov; 2011 Sep; 10(10):726. PubMed ID: 21959279
    [No Abstract]   [Full Text] [Related]  

  • 5. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 6. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 7. Mark Fishman. Interview by Asher Mullard.
    Fishman M
    Nat Rev Drug Discov; 2012 Jan; 11(1):14-5. PubMed ID: 22212670
    [No Abstract]   [Full Text] [Related]  

  • 8. David Urdal. Interview with Asher Mullard.
    Nat Rev Drug Discov; 2011 Oct; 10(11):806-7. PubMed ID: 22037031
    [No Abstract]   [Full Text] [Related]  

  • 9. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 10. An audience with… Fergus Sweeney. Interview by Asher Mullard.
    Sweeney F
    Nat Rev Drug Discov; 2011 May; 10(5):332. PubMed ID: 21532555
    [No Abstract]   [Full Text] [Related]  

  • 11. Alan Trounson. Interview by Asher Mullard.
    Trounson A
    Nat Rev Drug Discov; 2012 Jun; 11(7):512. PubMed ID: 22699775
    [No Abstract]   [Full Text] [Related]  

  • 12. An audience with... Nic Jones. Interview by Asher Mullard.
    Jones N
    Nat Rev Drug Discov; 2011 Apr; 10(4):252. PubMed ID: 21455228
    [No Abstract]   [Full Text] [Related]  

  • 13. An audience with... Jan M. Lundberg.
    Lundberg JM
    Nat Rev Drug Discov; 2005 Jun; 4(6):452. PubMed ID: 15959949
    [No Abstract]   [Full Text] [Related]  

  • 14. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 15. Paul Stoffels. Interview by Asher Mullard.
    Stoffels P
    Nat Rev Drug Discov; 2013 Apr; 12(4):258. PubMed ID: 23535929
    [No Abstract]   [Full Text] [Related]  

  • 16. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

  • 17. Growing pains in AIDS drug development.
    Herrera S
    Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440
    [No Abstract]   [Full Text] [Related]  

  • 18. An audience with… Henry Chesbrough. Interview by Asher Mullard.
    Chesbrough H
    Nat Rev Drug Discov; 2013 May; 12(5):338-9. PubMed ID: 23598507
    [No Abstract]   [Full Text] [Related]  

  • 19. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 20. Reverse vaccinology on the cusp.
    Jones D
    Nat Rev Drug Discov; 2012 Feb; 11(3):175-6. PubMed ID: 22322255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.